Zeke Capital Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$244K Buy
+2,155
New +$237K 0.02% 390
2022
Q2
Sell
-2,188
Closed -$280K 497
2022
Q1
$280K Buy
+2,188
New +$239K 0.01% 386
2020
Q2
Sell
-3,656
Closed -$246K 229
2020
Q1
$246K Sell
3,656
-14,508
-80% -$903K 0.07% 164
2019
Q4
$993K Buy
18,164
+1,484
+9% +$70.4K 0.08% 209
2019
Q3
$622K Sell
16,680
-2,740
-14% -$106K 0.06% 313
2019
Q2
$727K Hold
19,420
0.07% 267
2019
Q1
$578K Sell
19,420
-10,500
-35% -$369K 0.05% 325
2018
Q4
$896K Buy
+29,920
New +$949K 0.09% 220

Other funds holding DXCM

Zeke Capital Advisors's DXCM Position: Q4 2022 in Review

Zeke Capital Advisors opened a new position in DexCom (DXCM) in Q4 2022: 2,155 shares worth $244K. The stake represents 0.02% of the portfolio and ranks #390 among its holdings. This is a return to the name: Zeke Capital Advisors previously reported a position in DXCM as recently as Q1 2022.

Zeke Capital Advisors first reported a position in DXCM in Q4 2018 and has held it in 8 quarters since. The position peaked at $993K in Q4 2019. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

  • Zeke Capital Advisors held 2,155 shares of DexCom worth $244K as of Q4 2022.
  • DexCom was a new Zeke Capital Advisors position in Q4 2022.
  • DexCom made up 0.02% of Zeke Capital Advisors's portfolio in Q4 2022, its #390 holding.
  • Zeke Capital Advisors first reported a position in DexCom in Q4 2018 and has held it in 8 quarters since.
  • Zeke Capital Advisors's DexCom position peaked at $993K in Q4 2019.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.